Yubo International Biotech Ltd (YBGJ) shareholders
Close on Oct 16, 2026Market cap $886.19KP/E –Yield –
Ownership
Who owns Yubo International Biotech's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Jun Wang Joint filing with Flydragon International Ltd (48.10%) | 81,943,800 | 48.10% | 13D (active) amendment | Jul 23, 2025 |
| Chinaone Technology Ltd Joint filing with Yang Wang (15.10%) | 25,811,400 | 15.10% | 13D (active) amendment | Jul 23, 2025 |
| Boao Biotech Ltd Joint filing with Cao Yulin (16.60%) | 19,927,660 | 16.60% | 13G (passive) | Jan 25, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yang Wang | Chief Executive Officer, Director, 10% owner | 25,811,400 | 15.15% | Jul 25, 2025 |
| Jun Wang | President, Director, 10% owner | 81,943,800 | 48.08% | Jul 25, 2025 |
| Nanping Hu | Director | 0 | – | May 5, 2025 |
| Biotech Ltd Boao | 10% owner | 24,967,800 | 14.65% | Jun 3, 2025 |
| Yulin Cao | 10% owner | 19,927,660 | 11.69% | Jun 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Yang Wang Chief Executive Officer, Director, 10% owner | Jul 23, 2025 | Award | +8,600,000 | $0.05 | $430.00K | 25,811,400 |
| Jun Wang President, Director, 10% owner | Jul 23, 2025 | Award | +42,000,000 | $0.05 | $2.10M | 81,943,800 |
| Yang Wang Chief Executive Officer, Director, 10% owner | Jul 15, 2024 | Sale | −2,000,000 | $0.12 | $240.00K | 17,211,400 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −380,174 | $0.30 | $114.05K | 19,927,660 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −301,701 | $0.30 | $90.51K | 23,424,578 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −741,521 | $0.30 | $222.46K | 23,726,279 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −500,000 | $0.30 | $150.00K | 24,467,800 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −364,351 | $0.30 | $109.31K | 23,060,227 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −2,057,586 | $0.30 | $617.28K | 20,307,834 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −426,654 | $0.30 | $128.00K | 22,365,420 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −86,897 | $0.30 | $26.07K | 22,792,074 |
| Yulin Cao 10% owner | Jan 25, 2024 | Sale | −181,256 | $0.30 | $54.38K | 22,878,971 |
| Lina Liu Chief Financial Officer | Nov 9, 2022 | Sale | −4,728,000 | $0.50 | $2.36M | 9,101,400 |
| Draw Group Ltd Focus – | Sep 23, 2022 | Sale | −4,728,000 | $0.50 | $2.36M | 9,101,400 |
| Jun Wang President and CEO, Director, 10% owner | Jan 14, 2021 | Buy | +39,943,800 | – | – | 39,943,800 |
| Lina Liu CFO, Treasurer and Secretary | Jan 14, 2021 | Buy | +13,829,400 | – | – | 13,829,400 |
| Lina Liu CFO, Treasurer and Secretary | Jan 14, 2021 | Returned to company | −116,697,438 | – | – | 0 |
| Yang Wang Director, 10% owner | Jan 14, 2021 | Buy | +19,211,400 | – | – | 19,211,400 |
| Jonathan Adereth Director | Oct 31, 2005 | Award | +208,620 | $8000.00 | $1.67B | 208,620 |
| Seymour Kessler Director | Oct 31, 2005 | Award | +142,035 | $5417.00 | $769.40M | 142,035 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Yubo International Biotech's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?